Drug induced liver injury: Difference between revisions
YazanDaaboul (talk | contribs) No edit summary |
YazanDaaboul (talk | contribs) No edit summary |
||
Line 4: | Line 4: | ||
{{See Also|Hy's law}} | {{See Also|Hy's law}} | ||
'''For patient information, click [[Drug induced liver injury (patient information)|here]]'''<br><br> | '''For patient information, click [[Drug induced liver injury (patient information)|here]]'''<br><br> | ||
{{CMG}}<br> | {{CMG}} {{AE}}<br> | ||
{{SK}} DILI; Drug-induced liver injury; Drug induced hepatitis | {{SK}} DILI; Drug-induced liver injury; Drug induced hepatitis; drug induced liver toxicity | ||
==[[Drug induced liver injury overview|Overview]]== | ==[[Drug induced liver injury overview|Overview]]== |
Revision as of 13:01, 3 June 2016
Drug induced liver injury Microchapters |
Differentiating Drug Induced Liver Injury from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Drug Induced Liver Injury On the Web |
American Roentgen Ray Society Images of Drug induced liver injury |
Risk calculators and risk factors for Drug induced liver injury |
Template:See Also
Template:See Also
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Synonyms and keywords: DILI; Drug-induced liver injury; Drug induced hepatitis; drug induced liver toxicity
Overview
Historical Perspective
Pathophysiology
Classification
Causes
Differentiating Drug induced liver injury from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Liver Biopsy | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies